Nigeria Impact Startup Relief Facility 2020(Win up to $20,000 in grants)

The Nigeria Impact Startup Relief Facility(NISRF) is offering grants for Helping Early-Stage Impact Startups Survive the COVID-19 Crisis in 2020.

Nigeria Impact Startup Relief Facility (NISRF) is an emergency facility designed by a consortium of funding partners to disburse grants to a significant number of existing post-MVP stage high-growth startups who create impact so they remain viable during the COVID-19 crisis. NISRF is designed to support grant applicants whose businesses/activities are either being adversely affected by or modified in response to COVID-19.

RELATED:
Váradi Scholarships for International Students At University of London

Table of Contents

Worth of Award

  • Business equity-free funding between $5,000 to $20,000
  • Get access to a pool of mentors and business experts
  • Here’s your chance to continue to create impact and stay afloat.

Eligibility

In order to qualify for this funding, the following criteria have to be met:

  • Be a company operating in Nigeria
  • The company is tackling an urgent social problem
  • The company is post-MVP, revenue-generating, registered with CAC Can demonstrate solid financial health prior to the onset of COVID-19 (USD $60K ARR – 12 months period minimum)
  • The company has already received seed capital
  • Can demonstrate the scale of impact, or potential for future scale
  • Fall in any of these sectors: Agriculture, Critical Infrastructure, Financial Services, Health Care, Education, and with initiatives that target the informal sector.
  • How well you have optimised resources during COVID
RELATED:
University of Sydney International Strategic Scholarship

How to Apply

Submit your idea, concept, startup, or organization at any stage of development.

Deadline: applications close September 7, 2020.

 

Click here for more details and to apply

Subscribe to our newsletter!

Read From Original Source Here: 2020-2021 Scholarships, Fellowships and Opportunities for African Students

Be the first to comment

Leave a Reply

Your email address will not be published.


*